Tower Research Capital LLC (Trc) Acumen Pharmaceuticals, Inc. Transaction History
Tower Research Capital LLC (Trc)
- $3.29 Billion
- Q1 2025
A detailed history of Tower Research Capital LLC (Trc) transactions in Acumen Pharmaceuticals, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 8,441 shares of ABOS stock, worth $8,609. This represents 0.0% of its overall portfolio holdings.
Number of Shares
8,441
Previous 20,624
59.07%
Holding current value
$8,609
Previous $35,000
74.29%
% of portfolio
0.0%
Previous 0.0%
Shares
15 transactions
Others Institutions Holding ABOS
# of Institutions
83Shares Held
38.5MCall Options Held
39.1KPut Options Held
53.4K-
Ra Capital Management, L.P. Boston, MA14.9MShares$15.2 Million0.34% of portfolio
-
Sands Capital Ventures, LLC Arlington, VA3.42MShares$3.49 Million1.6% of portfolio
-
Franklin Resources Inc San Mateo, CA3.14MShares$3.2 Million0.0% of portfolio
-
Black Rock Inc. New York, NY2.16MShares$2.2 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.94MShares$1.98 Million0.0% of portfolio
About Acumen Pharmaceuticals, Inc.
- Ticker ABOS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 40,503,100
- Market Cap $41.3M
- Description
- Acumen Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for the treatment of Alzheimer's disease. The company focuses on advancing a targeted immunotherapy drug candidate ACU193, a humanized monoclonal antibody that is in Phase I clinical-stage to target soluble amyloid-beta oligomers. Acumen Ph...